Use this link to enable the ReciteMe accessibility toolkit Enable ReciteMe accessibility tools
Use this link to enable the ReciteMe accessibility toolkit

Accessibility tools

Enable ReciteMe accessibility tools
Home > Consultants > Professor Vijay Kunadian

Professor Vijay Kunadian

Professor Vijay Kunadian, is a Personal Chair, Professor of Interventional Cardiology specialising in acute coronary syndrome, myocardial infarction and chronic heart disease.

Professor Vijay Kunadian is a Consultant Interventional Cardiologist at Newcastle’s Freeman Hospital where she specialises in:

  • Acute coronary syndrome, myocardial infarction
  • Advanced intravascular imaging
  • Microvascular disease
  • Interventional Cardiology Clinical Research/Clinical Trials
  • Ageing and heart disease
  • Women and heart disease
  • Chronic disease and heart disease

Professor Kunadian is also a Personal Chair and Professor of Interventional Cardiology.

Qualifications

  • Women Transforming Leadership Programme, Said Business School, University of Oxford
  • Postgraduate Diploma in Clinical Trials, University of London (London School of Hygiene and Tropical Medicine), UK
  • FESC Fellow of the European Society of Cardiology, Europe
  • FACC Fellow of the American College of Cardiology, USA
  • FRCP Fellow of Royal College of Physicians Edinburgh, UK
  • MD Newcastle University, UK
  • MRCP Royal College of Physicians Edinburgh, UK
  • MBBS 

Postgraduate and Academic Training

  • General and Internal Medicine, Northern Deanery, UK
  • General and Interventional Cardiology, Northern Deanery, UK
  • Research Scholar: TIMI/PERFUSE Angiographic Core Lab, Brigham and Women’s Hospital, Harvard Medical School, Boston MA, USA
  • Research Registrar: The James Cook University Hospital, Middlesbrough, UK 

Awards, Honours, Fellowships

  • British Heart Foundation Alumni event Edinburgh 2019: Guest Speaker Bias and Biology, 2019
  • British Heart Foundation Guest Speaker Bias and Biology Campaign Leeds, 2019
  • NICOR – “Better than expected survival (at 2 standard deviation level), 30 days following percutaneous coronary intervention” 2015-2018 
  • UK Commissioner, The Lancet Commission- Cardiovascular Disease in Women, 2019
  • BBC News Campaign, The British Heart Foundation Bias and Biology, London 2019 
  • Panel Member, The British Heart Foundation Bias and Biology, London 2019
  • WINNER The Times, The Sunday Times We Are The City Healthcare RISING STAR Award 2018
  • Finalist We Are The City Healthcare RISING STAR Award 2018 Powered by The Times, The Sunday Times #watctop100
  • ITV Tyne Tees News, Public Health England Heart Age Campaign 2019 
  • European Society of Cardiology Educational Grant Award 2018 (VK Lead Supervisor)
  • British Cardiovascular Society Annual Conference Award 2018 (VK Lead Supervisor)
  • Newcastle Cardiovascular Research Centre Best Oral Abstract Award 2018 (VK Lead Supervisor) 
  • The Frank Knox Memorial Harvard Fellowship 2016-2017 (VK Lead Supervisor)
  • The Barbour Foundation Scholarship Award 2015-2016 (VK Lead Supervisor) 
  • Best abstract award ICON1 study, American College of Cardiology Scientific Sessions- Geriatric Cardiology Group 2015, San Diego 
  • Winning Moderated Poster Award, European Society of Cardiology Congress 2014, Barcelona
  • American Heart Association International Mentorship Award 2014 (VK Lead Supervisor)
  • Finalist, TCT 2010, Thomas J Linnemeier Young Investigator Award- Washington DC.

Roles and Responsibilities

Honorary Consultant Interventional Cardiologist, Freeman Hospital, Newcastle upon Tyne Hospital NHS Foundation Trust 

Newcastle University

  • Academic lead for Cardiology: Department of Health, Modernising Scientific Careers, MSc Cardiac Science Module, Newcastle University (2011-2020)
  • Academic lead for Cardiology: NIHR Academic Clinical Fellowship, Health Education North East (HENE) (2011-2020)
  • Academic lead for Cardiology: NIHR Academic Foundation Programme, HENE (2011-2020)
  • Academic lead for Cardiology: Cardiology Training Programme, HENE (2011-2020)
  • Associate Fellow: Graduate School, Newcastle University 
  • Lead Supervisor: MBBS Stage 4 SSC in Cardiology and Clinical Cardiology Research, Newcastle University 
  • Lead Supervisor: Masters by Research (MRes), Bachelor of Science (BSc), Biomedical Sciences, PhD, MD Cardiovascular Science, Newcastle University 

National and International

  • British Cardiovascular Intervention Society (BCIS): Steering Committee Member, Research and Development Group (2015 to Date)
  • Co-Chair, European Society of Cardiology ESC/European Association of Percutaneous Cardiovascular Interventions EAPCI Scientific Documents and Initiatives Committee ESC/EAPCI Board 2018-2020
  • European Society of Cardiology: Invited Member Education Committee (2018-2020)
  • European Society of Cardiology: Invited Member European Regulatory Affairs Committee (2018-2020)
  • European Society of Cardiology: Country Ambassador Patient Forum (2018-2020)
  • European Society of Cardiology/European Association of Percutaneous Cardiovascular Interventions (EAPCI): Steering Committee Member, Women’s Committee, International Collaborations Lead (2013-2020)
  • European Society of Cardiology/European Association of Percutaneous Cardiovascular Interventions (EAPCI): Steering Committee Member, Young Interventionalist Committee, Research Lead, Curriculum/Exam Development Committee, Representation in ESC Cardiologists of Tomorrow Committee on behalf of EAPCI Young (2013-2018)     
  • European Society of Cardiology/European Association of Percutaneous Cardiovascular Interventions (EAPCI): EUROPCR Programme Committee (2017, 2018, 2019)
  • European Society of Cardiology: Nucleus member, Working Group on Thrombosis
  • American College of Cardiology: Fellow, Abstract Reviewer, Scientific Sessions, USA
  • European Society of Cardiology: Fellow, Abstract Reviewer,  Faculty member, Scientific Sessions, Europe
  • Transcatheter Cardiovascular Therapeutics: Abstract Reviewer,  Faculty member, Scientific Sessions USA

Editorial Responsibilities

  • Heart- Associate Editor, Education in Heart
  • Circulation Cardiovascular Interventions-Editorial Board
  • European Heart Journal- Case Reports- Associate Editor
  • Advances in Interventional Cardiology- Associate Editor
  • Eurointervention Journal- Associate Editor
  • PCROnline Journal Club- Editorial Team Member
  • Eurointervention Journal- Social Media Editorial Team Member

Research

Group Name: ICON Study Group

https://www.ncl.ac.uk/medical-sciences/people/profile/vijaykunadian.html

https://pubmed.ncbi.nlm.nih.gov/?term=kunadian&sort=date

Despite significant developments in pharmacotherapy and interventional strategies, cardiovascular diseases remain the leading cause of death in the UK and worldwide. Moreover, there is a growing ageing and co-morbid population in whom the cardiovascular disease burden is very high. My group’s research interests thus far primarily focused on addressing the unmet needs of improving cardiovascular outcomes under the acronym ICON (Improve Cardiovascular Outcomes in High Risk PatieNts) in this neglected cohort of patients.

Chief Investigator:

  • ICON1 Study (Completed): Chief Investigator, Funder: Newcastle NIHR BRC (3 Years), UKCRN ID 12742.
  • APPLE-COPD: ICON 2 Study (Completed): Chief Investigator, Funder: Astra Zeneca (2 Years) 
  •  The British Heart Foundation SENIOR-RITA Trial (Ongoing): UK Chief Investigator, Funder: The British Heart Foundation Clinical Study Grant CS/15/7/31679 (7 Years)
  • ASPIRE Study (Completed): Chief Investigator, Funder: Research Capability Fund (2 Years)
  • TWILIGHT Study (Completed): UK National Coordinating Investigator, Sponsor: Mount Sinai School of Medicine New York, USA Funder: Astra Zeneca
  • XIENCE SHORT DAPT Trial (Completed): UK National Coordinating Investigator, Sponsor: Abbott Vascular Santa Clara, CA, USA Funder: Abbott Vascular
  • PACIFIC AMI Trial (Ongoing): UK National Coordinating Investigator, Sponsor: Bayer, Berlin, Germany Funder: Bayer, Berlin, Germany

Local Principal Investigator: 

  1. MVO/REFLOW MI Trial (Completed): Randomized Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside to Control for Attenuation of Microvascular Obstruction During Primary Percutaneous Coronary Intervention – UKCRN ID 12168
  2. EVOLVED Trial (Ongoing): Early valve replacement guided by biomarkers of left ventricular decompensation in asymptomatic patients with severe aortic stenosis NCT03094143
  3. COMPLETE Trial (Completed): A randomised, comparative effectiveness study of complete versus culprit-only revascularization strategies to treat multi-vessel disease after primary percutaneous coronary interventions for ST-segment elevation myocardial infarction – UKCRN ID 15425
  4. IDORSIA Trial (Completed): A multi-center, double-blind, randomized, placebo-controlled study to assess the pharmacodynamics, pharmacokinetics, tolerability, and safety of a single subcutaneous injection of ACT-246475 in adults with stable coronary artery disease
  5. ESC EORP Registry (Completed): Registry of management of NSTEMI patients
  6. Imodern (Ongoing):

Contact

Secretary: Carolanne Johnston – 0191 933 0214 (30214)